Low Level Laser Therapy
Laser Therapy


Specific Wavelength
Low level lasers use a specific wavelength of red light that stimulates the cell’s mitochondria to produce more ATP, the energy molecules of the cell. This activation of energy also turns on many other intracellular signaling pathways that increase tissue repair and regeneration. The lasers also directly interfere with the production of the inflammatory molecule prostaglandin E2. Thus, we use low level laser therapy to accelerate our patient’s healing time and consequently to shorten their total treatment time.
Infrared Laser Therapy
Low level lasers are considered class 2 lasers; this means the energy that is emitted by the lasers is low compared to other lasers that may be used to cut tissue or chelate blood vessels. You will not feel anything when the light photons hit your skin. This is an important distinction between low level laser therapy and infrared laser therapy. While both these lasers emit a red light, infrared laser therapy uses a wavelength of red light that produces heat that you will feel.

LASER
LLLT affects the function of connective tissue cells (fibroblasts), accelerate connective tissue repair and act as an anti-inflammatory agent.
Erchonia Laser Therapy
The use of low-level lasers is an effective means for reducing episodic chronic low back pain of musculoskeletal origin, progressively reducing low back pain over a 4-week treatment period and continuing to diminish it for at least an additional 8-weeks post-treatment. These improvements in pain were associated with reduced disability. Based off the results of this Randomized, Double-Blind, Sham-Controlled Study the Food and Drug Administration (FDA) the granted Erchonia® FX-635™ indication of use as an adjunct to provide relief of minor chronic low back pain of musculoskeletal origin, 510(k) # K180197. Test subjects will be followed out 12 months to determine the absolute limit of pain reduction.


Opioids and NSAIDs
Treatment Benefits
